Evidence map›Paper›PMID 30240896›Full record

ArticleHuman immunology2018

Allelic resolution NGS HLA typing of Class I and Class II loci and haplotypes in Cape Town, South Africa.

Yvonne R Thorstenson, Lisa E Creary, Huang Huang, Virginie Rozot, Tracy T Nguyen, Farbod Babrzadeh, Sandeep Kancharla, Marilyn Fukushima, Raquel Kuehn, Chunlin Wang and 6 more

Abstract read
In one paragraph

Article in Human immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yvonne R ThorstensonImmucor, Sirona Genomics, Mountain View, CA, USA. Electronic address: yrthor@gmail.com.
Lisa E CrearyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Huang HuangInstitute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA.
Virginie RozotSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Tracy T NguyenImmucor, Sirona Genomics, Mountain View, CA, USA.
Farbod BabrzadehImmucor, Sirona Genomics, Mountain View, CA, USA.
Sandeep KancharlaImmucor, Sirona Genomics, Mountain View, CA, USA.
Marilyn FukushimaImmucor, Sirona Genomics, Mountain View, CA, USA.
Raquel KuehnImmucor, Sirona Genomics, Mountain View, CA, USA.
Chunlin WangImmucor, Sirona Genomics, Mountain View, CA, USA.
Ming LiImmucor, Sirona Genomics, Mountain View, CA, USA.
Sujatha KrishnakumarImmucor, Sirona Genomics, Mountain View, CA, USA.
Michael MindrinosImmucor, Sirona Genomics, Mountain View, CA, USA.
Marcelo A Fernandez ViñaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Thomas J ScribaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Mark M DavisStanford University and Howard Hughes Medical Institute, Stanford, CA.

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
NIAID NIH HHS U19 AI057229
6 · The paper itself

Abstract

The development of next-generation sequencing (NGS) methods for HLA genotyping has already had an impact on the scope and precision of HLA research. In this study, allelic resolution HLA typing was obtained for 402 individuals from Cape Town, South Africa. The data were produced by high-throughput NGS sequencing as part of a study of T-cell responses to Mycobacterium tuberculosis in collaboration with the University of Cape Town and Stanford University. All samples were genotyped for 11 HLA loci, namely HLA-A, -B, -C, -DPA1, -DPB1, -DQA1, -DQB1, -DRB1, -DRB3, -DRB4, and -DRB5. NGS HLA typing of samples from Cape Town inhabitants revealed a unique cohort, including unusual haplotypes, and 22 novel alleles not previously reported in the IPD-IMGT/HLA Database. Eight novel alleles were in Class I loci and 14 were in Class II. There were 62 different alleles of HLA-A, 72 of HLA-B, and 47 of HLA-C. Alleles A∗23:17, A∗43:01, A∗29:11, A∗68:27:01, A∗01:23, B∗14:01:01, B∗15:10:01, B∗39:10:01, B∗45:07, B∗82:02:01 and C∗08:04:01 were notably more frequent in Cape Town compared to other populations reported in the literature. Class II loci had 21 different alleles of DPA1, 46 of DPB1, 27 of DQA1, 26 of DQB1, 41 of DRB1, 5 of DRB3, 4 of DRB4 and 6 of DRB5. The Cape Town cohort exhibited high degrees of HLA diversity and relatively high heterozygosity at most loci. Genetic distances between Cape Town and five other sub-Saharan African populations were also calculated and compared to European Americans.

Indexed as

AdolescentAllelesFemaleGene FrequencyGenotypeGenotyping TechniquesHaplotypesHigh-Throughput Nucleotide SequencingHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensHumansLinkage DisequilibriumMaleSouth AfricaHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensAllele frequencyGenetic distanceHaplotype frequencyHLALinkage disequilibriumNGSPopulation

Identifiers

PMID30240896
PMCPMC7011615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.